Clinical Trial Update: Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) [Phase 1, Phase 2]

View source ↗

Summary

The BATTLE-XRT trial, a Phase 1/2 study evaluating biomarker-driven targeted therapy with external beam radiation therapy for lung cancer, has been withdrawn. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: WITHDRAWN